Navigation Links
Dacogen in Medical News

SuperGen Reports 2008 Fourth Quarter and Year-End Financial Results

...at December 31, 2007. 2009 Financial Guidance The initial financial guidance for 2009 is as follows: Royalty revenue for dacogen is expected to increase up to 10% from the prior year to a range from $38 million to $42 million. Research and development expenses are expect...

Eisai Will Initiate First Head-to-Head Study Comparing Dacogen(R) (decitabine for injection) and Vidaza(R) (azacitidine) in Patients with Myelodysplastic Syndromes

...ings from this trial could help clarify the fundamental differences between dacogen and Vidaza and ultimately help clinicians with treatment selection," said D...w cases of MDS are diagnosed annually in the United States. About dacogen (R) Dacogen(R) (decitabine for injection) was approved by the U.S....

Dacogen comes to the rescue of MDS

... the body. Typical symptoms include weakness, fatigue, infections, easy bruising, bleeding, and fever. Hence the Food and Drug Administration approved dacogen injections for the treatment of MDS. These injections promote the normal development of blood cells. The FDA has given the drug an orphan drug sta...
Dacogen in Medical Technology

FDA Accepts sNDA for Alternative Dosing Regimen for Dacogen(R) (decitabine for injection) to Treat Patients with Myelodysplastic Syndromes (MDS)

...duction of functional blood cells. Currently, dacogen is approved for use as a three-day regimen, admini...linical development programs we have committed for dacogen and is a vital part of our human health care mis...to be sufficiently complete to review. About dacogen The safety profile of decitabine for injecti...

Dacogen(R) (decitabine for injection) Data Presented on a Phase II Clinical Trial in Elderly Patients with Acute Myeloid Leukemia (AML)

...rom our ongoing, global Phase III trial evaluating dacogen in elderly AML patients," said Edward B. Rubenstei...day support our commitment to continue to evaluate dacogen as a treatment option for elderly patients with AM...opulation and we look forward to seeing additional dacogen results reported." Besides myelosuppressi...

Eisai Provides Preliminary Efficacy Update On EORTC Phase III Trial of Dacogen(R) Versus Supportive Care in Patients With Myelodysplastic Syndromes

...ilar to those observed in other clinical trials of dacogen in patients with MDS. In the trial, conducted by t... for the Research and Treatment of Cancer (EORTC), dacogen was administered on a three-day dosing schedule. I...ase II trial (DACO-020) in which patients received dacogen every day for five days. The regimen was repeated ...

SuperGen Comments on Preliminary Efficacy Update on EORTC Phase 3 Trial of Dacogen(R) Versus Supportive Care in Patients With Myelodysplastic Syndromes

...monstrate a statistically significant advantage of dacogen treatment on median survival compared to BSC, the ...ilar to those observed in other clinical trials of dacogen in patients with MDS. The trial, conducted by the ...arch and Treatment of Cancer (EORTC), administered dacogen on a three-day dosing schedule in which the number...

Eisai's Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting

...or full prescribing information. About Dacogen dacogen (decitabine) for Injection was approved by the U.S...ational Prognostic Scoring System (IPSS) groups. dacogen may cause fetal harm when administered to a pregna...t to father a child while receiving treatment with dacogen and for two months afterwards. The most commonly o...

MGI Pharma, Inc. Summarizes Data Presented at the 2007 American Society of Clinical Oncology (ASCO) Annual Meeting

...ociety of Clinical Oncology (ASCO) Annual Meeting. dacogen (decitabine) for Injection was the subject of five... Dacogen(R) for Injection Study of Response to dacogen in Older Patients Diagnosed with Acute Myelogenous Leukemia (AML) The impact of dacogen on the survival of older patients with AML was pre...

MGI Pharma Summarizes Data Presented at the 2007 American Society of Clinical Oncology (ASCO) Annual Meeting

... Dacogen(R) for Injection Study of Response to dacogen in Older Patients Diagnosed with Acute Myelogenous Leukemia (AML) The impact of dacogen on the survival of older patients with AML was pre...teria. In the 33 patients treated with intravenous dacogen (100-150 mg/m2/course), an overall response rate r...
Dacogen in Biological Technology

SuperGen Reports 2008 Second Quarter Financial Results

... Quarterly dacogen Royalty Revenue Increases 76% from Same Prior Year... a Phase 3 trial, initiated in 2002, comparing dacogen to best supportive care (BSC) in elderly patie...trate a statistically significant advantage of dacogen treatment on median survival compared to BSC, the ...

SuperGen Reports 2008 First Quarter Financial Results

... dacogen Royalty Revenue Increases 114% from Same Prior Year Period DUBLIN, Calif....on schedule to begin Phase 1 clinical trials with SGI-1776 before year-end. dacogen royalty revenues have continued to largely offset our operating expenses an...

SuperGen Reports 2007 Fourth Quarter and Annual Financial Results

...re, compared with a net loss of $16.5 million, or $0.31 per fully diluted share, for the same prior year period. Highlights for 2007 include: -- dacogen royalty revenue was $22.3 million compared to $3.4 million for 2006. -- A major contributor to net income during 2007 was the gain on disposi...
Other Tags
(Date:4/20/2015)... April 20, 2015 The NFL draft season ... of players to add to their rosters, both for their ... In this episode of SCI TV , Vinnie ... acquisition of Greg Hardy given increased attention on off-field conduct ... year after the Ray Rice scandal brought media scrutiny, once ...
(Date:4/20/2015)... (PRWEB) April 20, 2015 Mutare ... has secured nationally-renowned Gastroenterologist Lawrence Kosinski, MD, MBA, ... , Dr. Kosinski brings a unique combination of ... to the Mutare Health team as ... communication, collaboration, and quality of care in the ...
(Date:4/20/2015)... The normal response from the doctor used to be, “He ... if the patient sought medical care after the six-hour treatment ... So it’s critical the patient’s loved ones or caregiver ask ... Not every emergency room physician or neurosurgeon has the training ... according to Ronald P. Benitez , neurosurgeon and president ...
(Date:4/20/2015)... Hills, CA (PRWEB) April 20, 2015 Genuine ... have tried diets and gym memberships in the past. But ... weight loss results can be guaranteed by adhering to ... a bad diet. No matter how many hours one spends ... all efforts to lose weight., But a nutritional mean plan ...
(Date:4/20/2015)... Montana (PRWEB) April 20, 2015 "It's ... has done for our family. Initially, I really thought ... where it would end. But what I've discovered is ... myself, to be together, support each other and walk ... Kori Keller. "I have learned way more from these ...
Breaking Medicine News(10 mins):Health News:Character Concerns in the NFL with Vinnie Iyer on SCI TV 2Health News:Dr. Lawrence Kosinski Merges Medical, Technical, Business Expertise as CMO for Mutare Health 2Health News:Dr. Lawrence Kosinski Merges Medical, Technical, Business Expertise as CMO for Mutare Health 3Health News:"What More Can Be Done?” – The Critical Question That Can Save a Stroke Victim 2Health News:"What More Can Be Done?” – The Critical Question That Can Save a Stroke Victim 3Health News:Guarantee Fat Loss Results With 5 Easy Tips 2Health News:Guarantee Fat Loss Results With 5 Easy Tips 3Health News:3 Years Later, Ramsey Keller Memorial Founder Reflects on Baby Loss, Giving Back by Paying for Infant Funerals in Montana and Receiving More Than She Will Ever Give 2Health News:3 Years Later, Ramsey Keller Memorial Founder Reflects on Baby Loss, Giving Back by Paying for Infant Funerals in Montana and Receiving More Than She Will Ever Give 3
(Date:3/31/2015)... NEW YORK , March 31, 2015  Elephant ... the "Company"), a global provider of Software Defined Network ... solutions, today announced total revenue of approximately $20.4 million ... to a restated $19.5 million for the year ended ... of calendar 2014, the Company had completed its multi-year ...
(Date:3/24/2015)... , Mar. 24, 2015 Research and Markets ... of the "Global Iris Recognition Market 2015-2019" ... the Global Iris Recognition market to grow at a ... This report covers the present scenario and the ... the period 2015-2019. To calculate the market size, the ...
(Date:3/23/2015)... BOSTON, Mass , March 23, 2015 SoundView ... shipment of NXT-ID,s (NASDAQ: NXTD ) Wocket smart wallet. SoundView ... world user feedback on their experience with the Wocket in ... experience at CVS, Whole Foods and other retailers, making both ... Kris Tuttle also says, "If the company meets ...
Breaking Biology News(10 mins):Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 2Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 3Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 4Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 5Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 6Global Iris Recognition Market 2015-2019 with 3M Cogent, Bioenable Technologies, Cross Match Technology, Iris ID Systems & Safran Dominating 2Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 2Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 3Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 4
Other Contents